Senti Biosciences, Inc. will present at the Leerink Partners 2026 Global Healthcare Conference in Miami, Florida on March 9, 2026 at 2:20 PM ET, featuring Timothy Lu, M.D., Ph.D., Co-Founder and Chief Executive Officer. Event materials include the company’s Events page (https://www.globenewswire.com/Tracker?data=eO4HQvIdopcKvgAJ0j1xhkPhzmnW3ejafteTBeSErN61GLAtY4adBx1qYPYxf7KQCdxOpiVzwbvwpoid-ztZREcGVkaRStXt31fWbx4hCKHH_Ea_NrJLhopWnD19yspa), the Investors section (https://www.globenewswire.com/Tracker?data=X7cFqDu9-39Ye9ggGYr5yP61YE2oO-DjF1Uov8CXsSHG4OA1I6E79BUl40fLchp-ypogjKR6Q7ddQIAreAhS0FZeNgMyi06q_jBFuIJI98k=), and the live webcast link (https://www.globenewswire.com/Tracker?data=AwJq_ahEOLDgYEHT39ZzYZob8sXUH2qgk7ywAnDTxuVogXDxj48O0jke3jaYiAfwgmu3hjqT2CmGTuLT_3BFm6fteqbd97EAO4tkskxU-GYZ-7_CH3aN8AgQq4hblLE7nLkjrDGmUavjVraqXfWRibPrMiLEXImpu1p29hZaiRYVG3caj8eM7tYNK9DVNB2s).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603030905PRIMZONEFULLFEED9662607) on March 03, 2026, and is solely responsible for the information contained therein.
Comments